Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf Treg therapy, in patients with…
MINNEAPOLIS, May 01, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies…
Phase 2 multicenter, open-label study (NCT07499102) will evaluate the safety and clinical efficacy of CK0801 Tregs in transfusion-dependent aplastic anemia.HOUSTON,…
REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing…
The groundbreaking ceremony was attended by a number of senior officials, marking the transition of AlUla Development Company into the execution…
Trianz's pivot from traditional IT services to a platform-led 'Transformation Services as a Software' business is substantially complete. Sudhakar Vadapalli…
Bharat Sanjaya Ventures joins as investor and strategic partnerCuppa plans franchise-led expansion across South India and global marketsBENGALURU, India, April…
GUANGZHOU, China, April 14, 2026 /PRNewswire/ -- Focusing on Advanced Manufacturing, Phase 1 of the 139th Canton Fair is set to…
SHANGHAI, April 10, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the first cohort of healthy…
DUBAI, United Arab Emirates, April 04, 2026 (GLOBE NEWSWIRE) -- As the crypto market looks ahead to 2026, $LOL is…